133 related articles for article (PubMed ID: 25758995)
1. No evidence for increased mortality in SDHD variant carriers compared with the general population.
van Hulsteijn LT; Heesterman B; Jansen JC; Bayley JP; Hes FJ; Corssmit EP; Dekkers OM
Eur J Hum Genet; 2015 Dec; 23(12):1713-6. PubMed ID: 25758995
[TBL] [Abstract][Full Text] [Related]
2. No difference in phenotype of the main Dutch SDHD founder mutations.
van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
[TBL] [Abstract][Full Text] [Related]
3. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
4. Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers.
Heesterman BL; de Pont LMH; van der Mey AG; Bayley JP; Corssmit EP; Hes FJ; Verbist BM; van Benthem PPG; Jansen JC
Eur J Hum Genet; 2018 Sep; 26(9):1339-1347. PubMed ID: 29777207
[TBL] [Abstract][Full Text] [Related]
5. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
[TBL] [Abstract][Full Text] [Related]
6. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
7. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
[TBL] [Abstract][Full Text] [Related]
8. Increased Mortality in
Rijken JA; van Hulsteijn LT; Dekkers OM; Niemeijer ND; Leemans CR; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Dreijerink KMA; van Dooren MF; Hes FJ; Jansen JC; Corssmit EPM; Hensen EF
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30658386
[TBL] [Abstract][Full Text] [Related]
9. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
11. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
[TBL] [Abstract][Full Text] [Related]
12. SDH mutations in patients affected by paraganglioma syndromes: a personal experience.
Mannelli M; Simi L; Ercolino T; Gaglianò MS; Becherini L; Vinci S; Sestini R; Gensini F; Pinzani P; Mascalchi M; Guerrini L; Pratesi C; Nesi G; Torti F; Cipollini F; Bernini GP; Genuardi M
Ann N Y Acad Sci; 2006 Aug; 1073():183-9. PubMed ID: 17102085
[TBL] [Abstract][Full Text] [Related]
13. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.
Timmers HJ; Pacak K; Bertherat J; Lenders JW; Duet M; Eisenhofer G; Stratakis CA; Niccoli-Sire P; Tran BH; Burnichon N; Gimenez-Roqueplo AP
Clin Endocrinol (Oxf); 2008 Apr; 68(4):561-6. PubMed ID: 17973943
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
16. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
17. Germline SDHD mutation in paraganglioma of the spinal cord.
Masuoka J; Brandner S; Paulus W; Soffer D; Vital A; Chimelli L; Jouvet A; Yonekawa Y; Kleihues P; Ohgaki H
Oncogene; 2001 Aug; 20(36):5084-6. PubMed ID: 11526495
[TBL] [Abstract][Full Text] [Related]
18. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.
Hensen EF; Jansen JC; Siemers MD; Oosterwijk JC; Vriends AH; Corssmit EP; Bayley JP; van der Mey AG; Cornelisse CJ; Devilee P
Eur J Hum Genet; 2010 Jan; 18(1):62-6. PubMed ID: 19584903
[TBL] [Abstract][Full Text] [Related]
19. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
20. Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.
Chatzikyriakou P; Touska P; Moonim MT; Obholzer R; Afridi S; Sandison A; Oakey RJ; Izatt L
Cancer Genet; 2021 Aug; 256-257():110-114. PubMed ID: 34107390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]